Skip to main content

Tagged With "skin patch"

Comment

Re: My Cowboy

Mum23 ·
Love the pumpkin patch fun!
Comment

Re: Kinley's skin test 4/13 15 months old

Mum23 ·
Aww. Hope the results helped you figure stuff out!
Comment

Re: Food Allergy Treatments Show Promising Results

josephine ·
As a mother of a son (age 11) who has been dealing with this allergy combo. since one, I agree with this article. We also have contact and air borne to same which just adds to it all. The important thing to remember is to read, read and read and know about everything that goes into your child's mouth. Cooking things at home is major too. My dream is that they will find a cure to all food allergies and to find resturants that actually can come up with something for my child to eat besides...
Comment

Re: Emma

Mamawebster ·
Thank You! She has a tree nut and sesame seed allergy. The picture was taken at a pumpkin patch in their maze.
Blog Post

DBV Submits Viaskin Peanut Treatment for FDA Biologics License

KFA News Team ·
DBV Technologies today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Viaskin Peanut for the treatment of peanut allergy in children four to 11 years of age. Viaskin Peanut is the Company’s lead product candidate, which is based on epicutaneous immunotherapy (EPIT), a proprietary technology platform that delivers biologically active compounds to the immune system
Blog Post

FDA Accepts Application for Viaskin Peanut Patch for Review

KFA News Team ·
DBV Technologies, a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for its investigational Viaskin® Peanut immunotherapy for the treatment of peanut-allergic children ages 4 to 11 years. Viaskin Peanut is the Company’s lead product candidate designed to potentially reduce the risk of life-threatening allergic reactions due to accidental exposure to peanuts.
Blog Post

FDA Allows Peanut Immunotherapy Treatments to Advance

KFA News Team ·
  The Food and Drug Administration (FDA) agreed to expedite the review of a specially formulated peanut product. The peanut product, called AR101, is being studied as a potential allergy treatment. The status was granted after the company...
Blog Post

FDA Fast Tracks Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy

KFA News Team ·
Kids With Food Allergies is sharing this press release from DBV Technologies . This is not an endorsement of the content contained in the press release. Speak with your physician if you have any questions. [PRESS RELEASE] Wednesday, September 21, 2016 DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy DBV first to announce Fast Track designation for IgE-mediated CMPA; Viaskin Milk is currently being investigated in a Phase...
Blog Post

FDA Gives Experimental Peanut Allergy Patch Special Status Designed to Speed Review

Kids With Food Allergies ·
The Food and Drug Administration agreed to review a skin patch for peanut allergy on an expedited basis following positive results of recent clinical trials, the company said Thursday.   DBV Technologies said that the FDA granted its Viaskin...
Blog Post

FDA Application for Peanut Patch for Children 4 to 11 Years of Age Is Withdrawn

KFA News Team ·
DBV Technologies today announced that after discussions with the U.S. Food and Drug Administration (FDA), its Biologics License Application (BLA) for Viaskin Peanut in children four to 11 years of age has been voluntarily withdrawn. DBV is currently working closely with the agency to resubmit the application for Viaskin Peanut as quickly as possible.
Blog Post

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

KFA News Team ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post Featured

Breaking News: FDA Approves Palforzia, a Ground-Breaking Peanut Allergy Oral Immunotherapy Treatment

KFA News Team ·
On Jan. 31, 2020, the U.S. Food and Drug Administration (FDA) announced its approval of Aimmune Therapeutics’ peanut treatment, Palforzia, for children ages 4 to 17. This is big news for the food allergy community. Food allergies put a significant mental, social and financial burden on families. Until now, strict avoidance has been the only way to avoid allergic reactions. Palforzia may give many families managing peanut allergies more freedom and greater quality of life.
Blog Post

College Student with Food Allergies Relies on Friends to Help Keep Herself Safe

Kids With Food Allergies ·
How is Valentine's Day different when you are diagnosed with multiple food allergies at 19? Kylee Christensen is 21 and is a college junior studying criminal justice in Illinois. At 19, she had a severe allergic reaction and was diagnosed allergic to multiple foods. Kids With Food Allergies and Kylee recently chatted online about how she manages romance, food allergies and college friendships while away at school. We spotted Kylee when she posted a picture of an "emergency box" she keeps in...
Blog Post

DBV Announces Phase III Trial Results for Viaskin Peanut

KFA News Team ·
DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
Blog Post

DBV Resubmits Viaskin Peanut Allergy Treatment to FDA

KFA News Team ·
DBV Technologies, a clinical-stage biopharmaceutical company, today announced the submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Viaskin® Peanut for the treatment of peanut-allergic children ages 4 to 11 years.
Blog Post

Act Now to Help Save Health Care Protections for Those With Food Allergies

Kids With Food Allergies ·
On Sept. 13, 2017, Senators Lindsey Graham (R-SC) and Bill Cassidy (R-LA) introduced a new bill to repeal the Affordable Care Act (ACA). The ACA includes protections for those with pre-existing conditions. Their goal is to vote on the repeal before Sept. 30, 2017. This bill, commonly called the Graham-Cassidy bill, could cause millions of Americans to lose health insurance. If passed, health insurance could become unaffordable for people with chronic conditions and low incomes.
Blog Post

Food Allergy Research Roundup 2017 Quarter 1

KFA News Team ·
Kids With Food Allergies will recap some of the top research in food allergies every three months. Here is a look at studies reported between January and March. Read about teens and food allergy, peanut allergy, secondhand smoke and more.
Blog Post

Food Allergy Research Update: Viaskin Study for Peanut Allergy

KFA News Team ·
Press Release: Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin(r) Peanut in Treatment of Peanut Allergy Leading US centers in food allergy involved in an NIH-funded CoFAR6 study,...
Blog Post Featured

Food Allergy Testing - What You Need to Know (Video & Resources)

Kids With Food Allergies ·
Kids With Food Allergies (KFA) , a division of the  Asthma and Allergy Foundation of America  hosted a free educational webinar on April 16, 2014 featuring guest speaker David Stukus, MD. Dr. Stukus reviewed the different types of food...
Blog Post

Food Allergy Treatments Show Promising Results

KFA News Team ·
A report from NBCNews explains two new treatments being studied: multiple food oral immunotherapy and a new skin patch. The treatments involve exposing the patient to a small amount of their allergen and slowly increasing the dose to build up...
Blog Post

Free Webinar: Food Allergy Testing

Kids With Food Allergies ·
FREE WEBINAR:   Food Allergy Testing RSVP:   Reserve your seat by registering WHEN:  Tuesday, April 15, 2014 TIME:  1:00 pm Eastern time WHERE:  Your computer, iOS or Android device When trying to determine whether a child has...
Blog Post

The Social and Emotional Impact of Raising Kids With Food Allergies: Insights from Parents (Video)

Kids With Food Allergies ·
On Aug. 21, 2019, Kenny Mendez, President and CEO of the Asthma and Allergy Foundation of America (AAFA), co-hosted a Facebook Live session with blogger Anna Luther of My Life and Kids. If you didn’t have a chance to tune in live, you can watch a replay of session. (Kids With Food Allergies is a division of AAFA.)
Blog Post

Treatment for Milk Allergy Shows Positive Results in Clinical Trial

Kids With Food Allergies ·
DBV Technologies today announced preliminary results from Part B, or Phase II, of a Phase I/II study evaluating the efficacy and safety of three dose regimens of Viaskin Milk (150 µg, 300 µg, 500 µg) in 198 patients for the treatment of IgE-mediated cow's milk protein allergy (CMPA). The MILES (Milk Efficacy and Safety) study was designed to determine a safe and effective dose in two age groups.
Blog Post

Tree Nut (Almonds) Allergy Alert - NadaMoo! Select Pints of Strawberry Cheesecake

KFA Food Alerts ·
NadaMoo! Voluntarily Recalls Select Pints of Strawberry Cheesecake Due to Undeclared Almond For Immediate Release April 1, 2019 Contact Consumers (512) 571-3870 march2019recall@nadamoo.com Announcement Little Red Rooster Ice Cream Company, d/b/a NadaMoo! (“NadaMoo!”) announced a limited voluntary recall of approximately 26,000 pints of its Strawberry Cheesecake Non-Dairy Frozen Dessert because they contain an undeclared almond ingredient. People who have an allergy or severe sensitivity to...
Blog Post

What Parents Need to Know About New Food Allergy Treatments (Video)

Kids With Food Allergies ·
On July 25, 2019, Kenny Mendez, President and CEO of the Asthma and Allergy Foundation of America (AAFA), co-hosted a Facebook Live session with pediatrician and blogger, Dr. Katie Freidman of Forever Freckled. If you didn’t have a chance to tune in live, you can still watch the session.
Blog Post

Peanut Allergy Oral Immunotherapy: Is Earlier Better?

KFA News Team ·
“Peanut allergy can have an adverse impact on quality of life for the child and family. Severe allergic reactions can occur with just a tiny ingestion of peanut allergen. A new NIH study provides encouraging news that children may be successfully treated with OIT for peanut allergy at a very young age.” – Lynda Mitchell, chief operating officer of the Asthma and Allergy Foundation of America What health issue did the study examine? We currently have no effective means to cure or treat food...
Blog Post

Peanut Allergy Patch Study Misses Its Main Goal in Third Phase

Kids With Food Allergies ·
Kids With Food Allergies is sharing this press release from DBV Technologies to bring you the latest research news quickly. [Press Release] DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut Allergic Patients Four to 11 Years of Age DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced topline results from the PEPITES (Peanut EPIT Efficacy and Safety) Phase III trial evaluating the safety and efficacy of Viaskin Peanut...
Blog Post

Peanut Patch Continues to Show Promise

KFA News Team ·
After the success of the yearlong double-blind, placebo controlled randomized Phase IIb trial for a peanut patch, known as Viaskin® Peanut, researchers continued the trial two more years in an open label extension to ascertain the effect of long-term treatment.
Blog Post

Peanut Patch Could Be Game Changer

Kids With Food Allergies ·
Now, doctors at New York's Mount Sinai Hospital and 23 other hospitals worldwide are testing what they hope will be a breakthrough treatment. It is a patch that exposes the wearer to small amounts of peanut protein through the skin. Over time, they...
Blog Post

Peanut Patch Shows Positive Results During Clinical Trial

KFA News Team ·
DBV Technologies, a clinical-stage biopharmaceutical company, today announced positive topline results of the three-year, open-label extension of the Phase III PEPITES trial (PEOPLE) evaluating the long-term efficacy and safety of investigational Viaskin® Peanut in peanut-allergic children ages 4 to 11 years. The results demonstrate long-term clinical benefit as shown by an increase in eliciting dose (ED), which may decrease the chance of reacting to an accidental peanut exposure.
Blog Post

Security Issue: Update Your Java Program Before KFA's Webinar

Kids With Food Allergies ·
A critical Java update has been released to patch a vulnerability in the software.  Java is used by many web applications including GoToWebinar--the program used by Kids With Food Allergies Foundation to host our online classes...
Blog Post

Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Kids With Food Allergies ·
Epicutaneous Immunotherapy (EPIT) introduces new way to treat peanut allergies   (Press Release)   Houston, TX – A team of researchers unveiled the results of their highly anticipated multi-national, double-blind, placebo controlled...
Blog Post

Milk Allergy Alert - NSE Products, Inc. in Ageloc TR90 Protein Boost

KFA Food Alerts ·
NSE Products, Inc. Issues Allergy Alert on Undeclared Milk in Ageloc TR90 Protein Boost For Immediate Release January 28, 2017 Contact Consumers Rod Anderson randerson@nuskin.com (801) 345-2188 Announcement NSE Products, Inc. is recalling all ageLOC TR90 Protein Boost because it contains milk in the formula, which is not declared on the label. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product.
Blog Post Featured

The Future of Food Allergy: Developing New Treatments

KFA Medical Advisors ·
The future of food allergy: developing new treatments   by Michael H. Land, MD FAAAAI   I'm the father of a food allergic child. If you're reading this, I am guessing you or someone close to you has a food allergy. The minute you found out...
Blog Post

Spread Awareness About the Impact of Eczema on Children With Food Allergies

Kids With Food Allergies ·
Eczema is common among children with food allergies. That's not surprising since they are both caused by reactions of the immune system. Atopic dermatitis (AD) is the most common form of eczema. Many people think of it as “dry skin” or “sensitive skin.” But people who don't know about AD aren't aware of the social, emotional and financial impact it can have on families who manage it.
Comment

Re: My Epi Backpack

This is the full bag.
Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)
-->
×
×
×
×